APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-based Clinical Trial Solution

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AI-based Clinical Trial Solution Industry Growth and Trends Forecast to 2032

15 January 2026114 pages

Choose your research edition.

Industry ResearchAI-based Clinical Trial Solution Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-based Clinical Trial Solution Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal AI-based Clinical Trial Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-based Clinical Trial Solution Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-based Clinical Trial Solution Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to APO Research, the global AI-based Clinical Trial Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-based Clinical Trial Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI-based Clinical Trial Solution market include AiCure, Antidote, Deep Lens, Saama Technologies, Trials.ai, Deep 6 AI, Innoplexus, Median Technologies and Mendel.ai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI-based Clinical Trial Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI-based Clinical Trial Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI-based Clinical Trial Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI-based Clinical Trial Solution.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI-based Clinical Trial Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI-based Clinical Trial Solution Market by Company

AiCure

Antidote

Deep Lens

Saama Technologies

Trials.ai

Deep 6 AI

Innoplexus

Median Technologies

Mendel.ai

Phesi

Tempus

IBM

Digital Reasoning

Insilico Medicine

Insitro

Evotec

PathAI

Cancer Center.ai

AI-based Clinical Trial Solution Segment by Type

Artificial Narrow Intelligence

Artificial General Intelligence

Artificial Super Intelligence

AI-based Clinical Trial Solution Segment by Application

Drug Discovery

Drug Manufacturing

Drug Marketing

Diagnosis and Treatment

Clinical Trials

AI-based Clinical Trial Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Clinical Trial Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-based Clinical Trial Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Clinical Trial Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI-based Clinical Trial Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI-based Clinical Trial Solution Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI-based Clinical Trial Solution Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI-based Clinical Trial Solution Market Share by Region (2021-2026) Table 4. Global AI-based Clinical Trial Solution Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI-based Clinical Trial Solution Market Share by Region (2027-2032) Table 6. Global AI-based Clinical Trial Solution Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI-based Clinical Trial Solution Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI-based Clinical Trial Solution Market Size Share by Type (2021-2026) Table 9. Global AI-based Clinical Trial Solution Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI-based Clinical Trial Solution Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI-based Clinical Trial Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI-based Clinical Trial Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI-based Clinical Trial Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI-based Clinical Trial Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI-based Clinical Trial Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI-based Clinical Trial Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI-based Clinical Trial Solution Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI-based Clinical Trial Solution Market Size Share by Application (2021-2026) Table 24. Global AI-based Clinical Trial Solution Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI-based Clinical Trial Solution Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI-based Clinical Trial Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI-based Clinical Trial Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI-based Clinical Trial Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI-based Clinical Trial Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI-based Clinical Trial Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI-based Clinical Trial Solution Industry Trends Table 37. AI-based Clinical Trial Solution Industry Drivers Table 38. AI-based Clinical Trial Solution Industry Opportunities and Challenges Table 39. AI-based Clinical Trial Solution Industry Restraints Table 40. Global AI-based Clinical Trial Solution Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI-based Clinical Trial Solution Revenue Market Share by Company (2021-2026) Table 42. Global AI-based Clinical Trial Solution Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI-based Clinical Trial Solution Key Company Headquarters & Area Served Table 44. Global AI-based Clinical Trial Solution Company, Product Type & Application Table 45. Global AI-based Clinical Trial Solution Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI-based Clinical Trial Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AiCure Company Information Table 49. AiCure Business Overview Table 50. AiCure AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AiCure AI-based Clinical Trial Solution Product Portfolio Table 52. AiCure Recent Development Table 53. Antidote Company Information Table 54. Antidote Business Overview Table 55. Antidote AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Antidote AI-based Clinical Trial Solution Product Portfolio Table 57. Antidote Recent Development Table 58. Deep Lens Company Information Table 59. Deep Lens Business Overview Table 60. Deep Lens AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Deep Lens AI-based Clinical Trial Solution Product Portfolio Table 62. Deep Lens Recent Development Table 63. Saama Technologies Company Information Table 64. Saama Technologies Business Overview Table 65. Saama Technologies AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Saama Technologies AI-based Clinical Trial Solution Product Portfolio Table 67. Saama Technologies Recent Development Table 68. Trials.ai Company Information Table 69. Trials.ai Business Overview Table 70. Trials.ai AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Trials.ai AI-based Clinical Trial Solution Product Portfolio Table 72. Trials.ai Recent Development Table 73. Deep 6 AI Company Information Table 74. Deep 6 AI Business Overview Table 75. Deep 6 AI AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Deep 6 AI AI-based Clinical Trial Solution Product Portfolio Table 77. Deep 6 AI Recent Development Table 78. Innoplexus Company Information Table 79. Innoplexus Business Overview Table 80. Innoplexus AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Innoplexus AI-based Clinical Trial Solution Product Portfolio Table 82. Innoplexus Recent Development Table 83. Median Technologies Company Information Table 84. Median Technologies Business Overview Table 85. Median Technologies AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Median Technologies AI-based Clinical Trial Solution Product Portfolio Table 87. Median Technologies Recent Development Table 88. Mendel.ai Company Information Table 89. Mendel.ai Business Overview Table 90. Mendel.ai AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Mendel.ai AI-based Clinical Trial Solution Product Portfolio Table 92. Mendel.ai Recent Development Table 93. Phesi Company Information Table 94. Phesi Business Overview Table 95. Phesi AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Phesi AI-based Clinical Trial Solution Product Portfolio Table 97. Phesi Recent Development Table 98. Tempus Company Information Table 99. Tempus Business Overview Table 100. Tempus AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Tempus AI-based Clinical Trial Solution Product Portfolio Table 102. Tempus Recent Development Table 103. IBM Company Information Table 104. IBM Business Overview Table 105. IBM AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. IBM AI-based Clinical Trial Solution Product Portfolio Table 107. IBM Recent Development Table 108. Digital Reasoning Company Information Table 109. Digital Reasoning Business Overview Table 110. Digital Reasoning AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Digital Reasoning AI-based Clinical Trial Solution Product Portfolio Table 112. Digital Reasoning Recent Development Table 113. Insilico Medicine Company Information Table 114. Insilico Medicine Business Overview Table 115. Insilico Medicine AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Insilico Medicine AI-based Clinical Trial Solution Product Portfolio Table 117. Insilico Medicine Recent Development Table 118. Insitro Company Information Table 119. Insitro Business Overview Table 120. Insitro AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Insitro AI-based Clinical Trial Solution Product Portfolio Table 122. Insitro Recent Development Table 123. Evotec Company Information Table 124. Evotec Business Overview Table 125. Evotec AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Evotec AI-based Clinical Trial Solution Product Portfolio Table 127. Evotec Recent Development Table 128. PathAI Company Information Table 129. PathAI Business Overview Table 130. PathAI AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. PathAI AI-based Clinical Trial Solution Product Portfolio Table 132. PathAI Recent Development Table 133. Cancer Center.ai Company Information Table 134. Cancer Center.ai Business Overview Table 135. Cancer Center.ai AI-based Clinical Trial Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio Table 137. Cancer Center.ai Recent Development Table 138. North America AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America AI-based Clinical Trial Solution Market Size by Country (2021-2026) & (US$ Million) Table 140. North America AI-based Clinical Trial Solution Market Share by Country (2021-2026) Table 141. North America AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America AI-based Clinical Trial Solution Market Share Forecast by Country (2027-2032) Table 143. Europe AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe AI-based Clinical Trial Solution Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe AI-based Clinical Trial Solution Market Share by Country (2021-2026) Table 146. Europe AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe AI-based Clinical Trial Solution Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific AI-based Clinical Trial Solution Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific AI-based Clinical Trial Solution Market Share by Country (2021-2026) Table 151. Asia-Pacific AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific AI-based Clinical Trial Solution Market Share Forecast by Country (2027-2032) Table 153. Latin America AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America AI-based Clinical Trial Solution Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America AI-based Clinical Trial Solution Market Share by Country (2021-2026) Table 156. Latin America AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America AI-based Clinical Trial Solution Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa AI-based Clinical Trial Solution Market Share by Country (2021-2026) Table 161. Middle East & Africa AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa AI-based Clinical Trial Solution Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI-based Clinical Trial Solution Product Image Figure 3. Global AI-based Clinical Trial Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI-based Clinical Trial Solution Market Size (2021-2032) & (US$ Million) Figure 5. Global AI-based Clinical Trial Solution Market Share by Region: 2025 VS 2032 Figure 6. Global AI-based Clinical Trial Solution Market Share by Region (2021-2032) Figure 7. North America AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Artificial Narrow Intelligence Image Figure 13. Global Artificial Narrow Intelligence Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Artificial General Intelligence Image Figure 15. Global Artificial General Intelligence Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Artificial Super Intelligence Image Figure 17. Global Artificial Super Intelligence Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global AI-based Clinical Trial Solution Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global AI-based Clinical Trial Solution Market Share by Type 2025 VS 2032 Figure 20. North America AI-based Clinical Trial Solution Market Size Share by Type (2021-2032) Figure 21. Europe AI-based Clinical Trial Solution Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific AI-based Clinical Trial Solution Market Size Share by Type (2021-2032) Figure 23. Latin America AI-based Clinical Trial Solution Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa AI-based Clinical Trial Solution Market Size Share by Type (2021-2032) Figure 25. Drug Discovery Image Figure 26. Global Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Drug Manufacturing Image Figure 28. Global Drug Manufacturing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Drug Marketing Image Figure 30. Global Drug Marketing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Diagnosis and Treatment Image Figure 32. Global Diagnosis and Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Clinical Trials Image Figure 34. Global Clinical Trials Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global AI-based Clinical Trial Solution Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global AI-based Clinical Trial Solution Market Share by Application 2025 VS 2032 Figure 37. North America AI-based Clinical Trial Solution Market Size Share by Application (2021-2032) Figure 38. Europe AI-based Clinical Trial Solution Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific AI-based Clinical Trial Solution Market Size Share by Application (2021-2032) Figure 40. Latin America AI-based Clinical Trial Solution Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa AI-based Clinical Trial Solution Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 AI-based Clinical Trial Solution Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America AI-based Clinical Trial Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America AI-based Clinical Trial Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 47. Europe AI-based Clinical Trial Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe AI-based Clinical Trial Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 50. Asia-Pacific AI-based Clinical Trial Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific AI-based Clinical Trial Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 53. Latin America AI-based Clinical Trial Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America AI-based Clinical Trial Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 56. Middle East & Africa AI-based Clinical Trial Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa AI-based Clinical Trial Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa AI-based Clinical Trial Solution Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Artificial Narrow Intelligence
  • Artificial General Intelligence
  • Artificial Super Intelligence
Applications
  • Drug Discovery
  • Drug Manufacturing
  • Drug Marketing
  • Diagnosis and Treatment
  • Clinical Trials
Companies covered
  • AiCure
  • Antidote
  • Deep Lens
  • Saama Technologies
  • Trials.ai
  • Deep 6 AI
  • Innoplexus
  • Median Technologies
  • Mendel.ai
  • Phesi
  • Tempus
  • IBM
  • Digital Reasoning
  • Insilico Medicine
  • Insitro
  • Evotec
  • PathAI
  • Cancer Center.ai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI-based Clinical Trial Solution Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI-based Clinical Trial Solution Market Size by Region (2021-2032)
  5. 1.4.1 Global AI-based Clinical Trial Solution Market Size by Region (2021-2026)
  6. 1.4.2 Global AI-based Clinical Trial Solution Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI-based Clinical Trial Solution Market Size (2021-2032)
  8. 1.5.1 North America AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI-based Clinical Trial Solution Market Size Growth Rate (2021-2032)
2 AI-based Clinical Trial Solution Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Artificial Narrow Intelligence
  3. 2.1.2 Artificial General Intelligence
  4. 2.1.3 Artificial Super Intelligence
  5. 2.2 Global AI-based Clinical Trial Solution Market Size by Type
  6. 2.2.1 Global AI-based Clinical Trial Solution Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global AI-based Clinical Trial Solution Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global AI-based Clinical Trial Solution Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global AI-based Clinical Trial Solution Market Size by Regions
  10. 2.3.1 North America AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa AI-based Clinical Trial Solution Market Size Breakdown by Type (2021-2026)
3 AI-based Clinical Trial Solution Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Drug Discovery
  3. 3.1.2 Drug Manufacturing
  4. 3.1.3 Drug Marketing
  5. 3.1.4 Diagnosis and Treatment
  6. 3.1.5 Clinical Trials
  7. 3.2 Global AI-based Clinical Trial Solution Market Size by Application
  8. 3.2.1 Global AI-based Clinical Trial Solution Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global AI-based Clinical Trial Solution Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global AI-based Clinical Trial Solution Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global AI-based Clinical Trial Solution Market Size by Regions
  12. 3.3.1 North America AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa AI-based Clinical Trial Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI-based Clinical Trial Solution Industry Trends
  2. 4.2 AI-based Clinical Trial Solution Industry Drivers
  3. 4.3 AI-based Clinical Trial Solution Industry Opportunities and Challenges
  4. 4.4 AI-based Clinical Trial Solution Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI-based Clinical Trial Solution Revenue (2021-2026)
  2. 5.2 Global AI-based Clinical Trial Solution Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI-based Clinical Trial Solution Key Company Headquarters & Area Served
  4. 5.4 Global AI-based Clinical Trial Solution Company, Product Type & Application
  5. 5.5 Global AI-based Clinical Trial Solution Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI-based Clinical Trial Solution Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI-based Clinical Trial Solution Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI-based Clinical Trial Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AiCure
  2. 6.1.1 AiCure Company Information
  3. 6.1.2 AiCure Business Overview
  4. 6.1.3 AiCure AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AiCure AI-based Clinical Trial Solution Product Portfolio
  6. 6.1.5 AiCure Recent Developments
  7. 6.2 Antidote
  8. 6.2.1 Antidote Company Information
  9. 6.2.2 Antidote Business Overview
  10. 6.2.3 Antidote AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Antidote AI-based Clinical Trial Solution Product Portfolio
  12. 6.2.5 Antidote Recent Developments
  13. 6.3 Deep Lens
  14. 6.3.1 Deep Lens Company Information
  15. 6.3.2 Deep Lens Business Overview
  16. 6.3.3 Deep Lens AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Deep Lens AI-based Clinical Trial Solution Product Portfolio
  18. 6.3.5 Deep Lens Recent Developments
  19. 6.4 Saama Technologies
  20. 6.4.1 Saama Technologies Company Information
  21. 6.4.2 Saama Technologies Business Overview
  22. 6.4.3 Saama Technologies AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Saama Technologies AI-based Clinical Trial Solution Product Portfolio
  24. 6.4.5 Saama Technologies Recent Developments
  25. 6.5 Trials.ai
  26. 6.5.1 Trials.ai Company Information
  27. 6.5.2 Trials.ai Business Overview
  28. 6.5.3 Trials.ai AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Trials.ai AI-based Clinical Trial Solution Product Portfolio
  30. 6.5.5 Trials.ai Recent Developments
  31. 6.6 Deep 6 AI
  32. 6.6.1 Deep 6 AI Company Information
  33. 6.6.2 Deep 6 AI Business Overview
  34. 6.6.3 Deep 6 AI AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Deep 6 AI AI-based Clinical Trial Solution Product Portfolio
  36. 6.6.5 Deep 6 AI Recent Developments
  37. 6.7 Innoplexus
  38. 6.7.1 Innoplexus Company Information
  39. 6.7.2 Innoplexus Business Overview
  40. 6.7.3 Innoplexus AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Innoplexus AI-based Clinical Trial Solution Product Portfolio
  42. 6.7.5 Innoplexus Recent Developments
  43. 6.8 Median Technologies
  44. 6.8.1 Median Technologies Company Information
  45. 6.8.2 Median Technologies Business Overview
  46. 6.8.3 Median Technologies AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Median Technologies AI-based Clinical Trial Solution Product Portfolio
  48. 6.8.5 Median Technologies Recent Developments
  49. 6.9 Mendel.ai
  50. 6.9.1 Mendel.ai Company Information
  51. 6.9.2 Mendel.ai Business Overview
  52. 6.9.3 Mendel.ai AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Mendel.ai AI-based Clinical Trial Solution Product Portfolio
  54. 6.9.5 Mendel.ai Recent Developments
  55. 6.10 Phesi
  56. 6.10.1 Phesi Company Information
  57. 6.10.2 Phesi Business Overview
  58. 6.10.3 Phesi AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Phesi AI-based Clinical Trial Solution Product Portfolio
  60. 6.10.5 Phesi Recent Developments
  61. 6.11 Tempus
  62. 6.11.1 Tempus Company Information
  63. 6.11.2 Tempus Business Overview
  64. 6.11.3 Tempus AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Tempus AI-based Clinical Trial Solution Product Portfolio
  66. 6.11.5 Tempus Recent Developments
  67. 6.12 IBM
  68. 6.12.1 IBM Company Information
  69. 6.12.2 IBM Business Overview
  70. 6.12.3 IBM AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 IBM AI-based Clinical Trial Solution Product Portfolio
  72. 6.12.5 IBM Recent Developments
  73. 6.13 Digital Reasoning
  74. 6.13.1 Digital Reasoning Company Information
  75. 6.13.2 Digital Reasoning Business Overview
  76. 6.13.3 Digital Reasoning AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Digital Reasoning AI-based Clinical Trial Solution Product Portfolio
  78. 6.13.5 Digital Reasoning Recent Developments
  79. 6.14 Insilico Medicine
  80. 6.14.1 Insilico Medicine Company Information
  81. 6.14.2 Insilico Medicine Business Overview
  82. 6.14.3 Insilico Medicine AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Insilico Medicine AI-based Clinical Trial Solution Product Portfolio
  84. 6.14.5 Insilico Medicine Recent Developments
  85. 6.15 Insitro
  86. 6.15.1 Insitro Company Information
  87. 6.15.2 Insitro Business Overview
  88. 6.15.3 Insitro AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Insitro AI-based Clinical Trial Solution Product Portfolio
  90. 6.15.5 Insitro Recent Developments
  91. 6.16 Evotec
  92. 6.16.1 Evotec Company Information
  93. 6.16.2 Evotec Business Overview
  94. 6.16.3 Evotec AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Evotec AI-based Clinical Trial Solution Product Portfolio
  96. 6.16.5 Evotec Recent Developments
  97. 6.17 PathAI
  98. 6.17.1 PathAI Company Information
  99. 6.17.2 PathAI Business Overview
  100. 6.17.3 PathAI AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 PathAI AI-based Clinical Trial Solution Product Portfolio
  102. 6.17.5 PathAI Recent Developments
  103. 6.18 Cancer Center.ai
  104. 6.18.1 Cancer Center.ai Company Information
  105. 6.18.2 Cancer Center.ai Business Overview
  106. 6.18.3 Cancer Center.ai AI-based Clinical Trial Solution Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Cancer Center.ai AI-based Clinical Trial Solution Product Portfolio
  108. 6.18.5 Cancer Center.ai Recent Developments
7 North America
  1. 7.1 North America AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  3. 7.3 North America AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  3. 8.3 Europe AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  3. 10.3 South America AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI-based Clinical Trial Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI-based Clinical Trial Solution Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI-based Clinical Trial Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst